RedHill Biopharma Stock (NASDAQ:RDHL)
Previous Close
$6.47
52W Range
$6.34 - $82.00
50D Avg
$8.45
200D Avg
$10.55
Market Cap
$8.20M
Avg Vol (3M)
$44.21K
Beta
3.67
Div Yield
-
RDHL Company Profile
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its clinical late-stage investigational development programs include RHB-204, which is in Phase 3 study for pulmonary nontuberculous mycobacteria infections; opaganib (Yeliva), an SK2 selective inhibitor, which has completed Phase 2 study to treat patients with SARS-CoV-2 severe COVID-19 pneumonia, in Phase 2 study to treat advanced unresectable cholangiocarcinoma, and in investigator-sponsored Phase 2 study to treat prostate cancer; RHB-107, which is in Phase 2/3 study to treat outpatients infected with COVID-19 disease, and preclinical evaluation study to treat advanced unresectable cholangiocarcinoma, as well as has completed Phase 2 study to treat gastrointestinal and other solid tumors; RHB-104, which is in Phase 3 studies for Crohn's disease; RHB-102 (Bekinda) that is in Phase 3 studies for acute gastroenteritis and gastritis, and has completed Phase 2 studies for irritable bowel syndrome with diarrhea; and RHB-106, an encapsulated formulation for bowel preparation, which is preparing for Phase 2/3 study. RedHill Biopharma Ltd. was incorporated in 2009 and is headquartered in Tel Aviv, Israel.
RDHL Performance
Peer Comparison
Ticker | Company |
---|---|
EVOK | Evoke Pharma, Inc. |
TKNO | Alpha Teknova, Inc. |
AQST | Aquestive Therapeutics, Inc. |
LFCR | Lifecore Biomedical, Inc. |
ORGO | Organogenesis Holdings Inc. |
GHSI | Guardion Health Sciences, Inc. |
ALIM | Alimera Sciences, Inc. |
PTPI | Petros Pharmaceuticals, Inc. |
ACRX | Talphera, Inc. |
CPIX | Cumberland Pharmaceuticals Inc. |
ADMP | Adamis Pharmaceuticals Corporation |
CYTH | Cyclo Therapeutics, Inc. |
PRFX | PainReform Ltd. |
AGRX | Agile Therapeutics, Inc. |
COLL | Collegium Pharmaceutical, Inc. |
SXTC | China SXT Pharmaceuticals, Inc. |